Real-World Analysis of Patients With C3 Glomerulopathy in the United States
In a real-world US population of patients with C3G, we identified a population with both advanced kidney disease around the time of diagnosis and high rates of CKD stage progression, highlighting the need to utilize novel treatments to improve patient outcomes.
Authors
- James Signorovitch (ORCID: https://orcid.org/0000-0002-4067-8962)
- Irina Pivneva (ORCID: https://orcid.org/0000-0003-1101-5200)
- Carolina Aldworth
- Marie Louise Edwards
- Annika Anderson (ORCID: https://orcid.org/0000-0001-6319-9959)
- Pietro A. Canetta
- Jennifer Nguyen
- Briana C. Ndife
Institutions
- Columbia University Irving Medical Center (US)
- Novartis (United States) (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1016/j.ekir.2026.103773
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00